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Most organisms use endogenous timekeeping 
mechanisms to coordinate their physiology with the 
external cycle of day and night. These circadian 
rhythms have a cell-autonomous basis (Balsalobre 
et al., 1998; Welsh et al., 2004) orchestrating many cel-
lular functions, such as DNA repair, protein synthe-
sis, and cell division, to an approximately 24-h beat 
(Dekens et al., 2003; Kang et al., 2009; Lipton et al., 
2015; Matsuo et al., 2003). Circadian rhythms bestow 
a selective advantage upon organisms in rhythmic 
and arrhythmic settings by synchronising them with 
predictable daily environmental cycles and facilitat-
ing the temporal segregation of mutually antagonis-
tic processes (Beale et  al., 2016; Vaze and Sharma, 
2013). In most cell types, these temporal programs are 
thought to be dependent on the rhythmic regulation 
of gene expression by oscillating “clock gene” activ-
ity, in turn facilitated by transcriptional feedback 
repression of clock gene transcription by their own 
protein products (Takahashi, 2017).
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Abstract Temperature compensation and period determination by casein 
kinase 1 (CK1) are conserved features of eukaryotic circadian rhythms, whereas 
the clock gene transcription factors that facilitate daily gene expression rhythms 
differ between phylogenetic kingdoms. Human red blood cells (RBCs) exhibit 
temperature-compensated circadian rhythms, which, because RBCs lack nuclei, 
must occur in the absence of a circadian transcription-translation feedback 
loop. We tested whether period determination and temperature compensation 
are dependent on CKs in RBCs. As with nucleated cell types, broad-spectrum 
kinase inhibition with staurosporine lengthened the period of the RBC clock at 
37°C, with more specific inhibition of CK1 and CK2 also eliciting robust 
changes in circadian period. Strikingly, inhibition of CK1 abolished tempera-
ture compensation and increased the Q10 for the period of oscillation in RBCs, 
similar to observations in nucleated cells. This indicates that CK1 activity is 
essential for circadian rhythms irrespective of the presence or absence of clock 
gene expression cycles.
Keywords casein kinase, temperature compensation, erythrocyte, dielectrophoresis, 
electrophysiology
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Transcriptional oscillations are not essential for 
circadian rhythms; bona fide circadian rhythms 
occur in the complete absence of transcription in the 
alga Ostreococcus tauri (O’Neill et  al., 2011), in 
human red blood cells (RBCs) (O’Neill and Reddy, 
2011), and in other organisms (Lakin-Thomas, 2006; 
Tomita et  al., 2005; Woolum, 1991). Importantly, 
these examples of transcription-independent circa-
dian rhythms satisfy the 3 fundamental properties 
that define circadian clocks (Pittendrigh, 1960): they 
are entrained by relevant environmental cues, such 
as light or temperature; they free run with an 
approximately 24-h period; and they are tempera-
ture compensated, meaning that they do not run 
faster at higher temperatures, i.e., Q10 ≈ 1, unlike 
most chemical and biochemical reactions, where 
Q10 ≈ 2.
Although temperature compensation is a defin-
ing feature of circadian clocks, it remains poorly 
understood. Some period-determining processes, 
and thus candidate mechanisms that facilitate tem-
perature compensation, are known, and these tend 
to involve the phosphorylation of clock proteins by 
Ser/Thr kinases (Gallego and Virshup, 2007). One 
important and evolutionarily conserved post-trans-
lational modifier is casein kinase 1 (CK1), which 
phosphorylates non-orthologous clock protein tar-
gets, such as PERIOD (PER) in mammals and 
FREQUENCY (FRQ) in fungi (He et al., 2006; Meng 
et al., 2008), and has been shown to regulate period 
and temperature compensation of circadian rhythms 
across eukaryotes (Causton et  al., 2015; He et  al., 
2006; Hirota et al., 2010; Meng et al., 2008; van Ooijen 
et al., 2013).
Whilst mutation of individual PERIOD homologs 
can alter circadian period by several hours, these per-
turbations have only modest effects on temperature 
compensation (Dibner et  al., 2009). Recently, it was 
shown that CK1δ/ε-dependent phosphorylation is 
intrinsically temperature compensated, with a CK1-
specific domain around K224 sufficient to confer tem-
perature compensation on other kinases (Isojima 
et al., 2009; Shinohara et al., 2017). Since temperature 
compensation and the circadian function of CK1 
exhibit far greater evolutionary conservation than any 
known clock protein substrate or clock gene transcrip-
tional circuit, we hypothesised that the timekeeping 
and temperature compensation function of CK1 might 
extend beyond its known interaction with clock gene 
transcriptional circuits to include transcription-inde-
pendent circadian rhythms. Here, we employed a 
reduced model of non-transcriptional circadian 
rhythms—isolated human RBCs—to test whether 
period determination and temperature compensation 
remain dependent on CK1 activity in the absence of 
clock protein expression and cycling transcription.
Materials and Methods
experimental Model and subject details
Studies were conducted in accordance with the 
principles of the Declaration of Helsinki, with 
approval/favourable opinion from our local Research 
Ethics Committee. Participants in the study were 
screened for relevant self-reported health issues, 
including sleep disorders or excessive daytime sleep-
iness. All participants provided written, informed 
consent after having received a detailed explanation 
of the study procedures. RBCs were isolated from 
male participants, with RBCs from 4 separate donors 
for each treatment or experimental condition.
human rBC isolation
RBCs were isolated following the protocol of 
Henslee et al. (2017). RBCs were isolated from antico-
agulant-treated whole blood (lithium heparin 
Vacutainer, BD Biosciences; Franklin Lakes, NJ) by 
density gradient centrifugation, layering a mixture 
(1:2.67) of whole blood and Dulbecco’s phosphate-
buffered saline (DPBS; Sigma-Aldrich, St Louis, MO) 
on top of Histopaque-1077 (Sigma-Aldrich) at 50 ×g 
for 30 min. RBCs were washed once in DPBS (250 ×g 
for 15 min) and once in modified Krebs-Henseleit 
buffer (KHB; Sigma-Aldrich) (250 ×g for 10 min). 
KHB was modified by supplementation with calcium 
chloride dihydrate (to a final concentration of 2.54 
mM), sodium bicarbonate (25 mM), bovine serum 
albumin (1 g/l), penicillin (100 U/l ) and streptomy-
cin (100 µg/l), and adjusted to pH 7.4 and 290-299 
mOsm. After washing, 330 µl of packed RBCs were 
added to 40 ml of KHB.
Circadian entrainment
RBCs were subjected to daily temperature cycles 
(12 h, 37°C; 12 h, 32°C) for 2 days using a programmed 
thermal cycler before transfer into constant tempera-
ture conditions of either 37°C or 32°C (as specified). 
Samples were taken at 3- or 4-hourly intervals upon 
transfer into constant conditions, with a single 500-µl 
PCR tube of RBCs at each time point for each donor. 
Following convention, the transition to constant con-
ditions was taken as t = 0.
dielectrophoresis
After the 48-h entrainment, at each timepoint, a 
single PCR tube was removed from the thermal cycler 
to assess cell electrophysiology by dielectrophoresis 
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(DEP). The modified KHB medium was removed and 
the pellet was suspended in iso-osmotic DEP medium 
(248 mM sucrose, 16.7 mM dextrose, 250 mM MgCl2, 
100 mM CaCl2, adjusted to 290-299 mOsm and a con-
ductivity of 0.043 S/m using DPBS). Cells in DEP 
medium were then centrifuged for 2 min at 500 ×g, 
and the medium was replaced with fresh DEP 
medium to reduce ionic carryover from the high ionic 
strength of the KHB medium. The cells were subse-
quently adjusted to a final concentration of 106 per ml 
and pipetted into 3DEP chips (Labtech; Heathfield, 
East Sussex, UK). Chips were analysed by a 3DEP 3D 
Dielectrophoresis Cell Analysis System (3DEP reader, 
Labtech). The wells were energised for 30 s at 10 Vp–
p, at 20 frequencies between 10 kHz and 20 MHz. This 
was repeated 3 to 4 times for each donor at each time 
point. The raw data were fitted with a single-shell 
model using 3DEP software (v1.2, Labtech, https://
www.labtech.com/3dep-3d-dielectrophoresis-cell-
analysis-system) to extract the electrophysiological 
parameters; models that produced an R value 
(Pearson correlation coefficient) of 0.95 or lower were 
excluded.
Bioluminescence imaging
Human U2OS cells (HTB-96, ATCC; Manassas, 
VA) were stably transfected with BMAL1:Luc and cul-
tured in Dulbecco’s Modified Essential Medium 
(DMEM) supplemented with 10% HyClone 
FetalClone II Serum (Thermo Fisher Scientific; 
Waltham, MA), 1 mM luciferin (Biosynth AG; Staad, 
Switzerland), 100 U/mL penicillin, 100 μg/mL strep-
tomycin, and 2 μg/mL puromycin (to maintain selec-
tion). Four days before bioluminescence imaging, 
cells were trypsinized, resuspended in culture 
medium, seeded into six 96-well white plates at a 
density of 104 cells per well, and incubated in a 
humidified incubator for 96 h (37°C, 5% CO2) under 
daily applied temperature cycles (12 h 32°C; 12 h 
37°C). At 4 h before the anticipated transition to the 
warm phase, cell media was exchanged for recording 
media (± drug or vehicle) and the plates were placed 
into an ALLIGATOR for bioluminescence imaging, 
and were maintained at a constant temperature and 
5% CO2 (Crosby et  al., 2017). The recording media 
was identical to the culture media except that the 
serum concentration was reduced to 1%; B27 supple-
ment (Thermo Fisher) was added to a final concentra-
tion of 2%, and puromycin was omitted. For constant 
culture conditions at 40°C, cells were plated as above 
but, rather than being subjected to daily temperature 
cycles, incubation temperature was increased by 1°C 
per day from 37°C to 40°C to acclimate cells to the 
higher temperature. Cells were synchronised on the 
fourth day after plating, with the media changed to 
media containing B27, as described above. 
Bioluminescence levels were integrated every 30 min 
without EM gain.
Gel electrophoresis and immunoblotting
RBC pellets were lysed by trituration in 200 µl 1× 
LDS sample buffer (Thermo Fisher Scientific) supple-
mented with 10 mM TCEP. Before electrophoresis, 
samples were heated at 70°C for 10 min on a heat 
block. Western blotting and SDS-PAGE were per-
formed using the NuPage Novex mini system (Thermo 
Fisher Scientific) with 4% to 12% bis-tris gradient gels 
and nitrocellulose transfer stacks, used according to 
the manufacturer’s instructions. Blots were blocked in 
5% (w/v) non-fat dried milk (Marvel) dissolved in 
Tris-buffered saline containing 0.05% Tween-20 (TBST) 
for 1 h at room temperature, and then incubated over-
night at 4°C on a rotary shaker with primary antibod-
ies diluted in blocking buffer. Primary antibodies were 
as follows: rabbit anti-CK1α (1:1000, ab108296; Abcam, 
Cambridge, UK), mouse anti-CK1δ (1:1000, ab85320; 
Abcam), mouse anti-CK1ε (1:2000, ab82426; Abcam), 
rabbit anti-CK2α‘ (1:1000, ab10474; Abcam) and rabbit 
anti-CK2β (1:1000, ab133576; Abcam). Blots were 
washed for 3 × 5 min in TBST then incubated for 1 h 
with HRP-conjugated anti-rabbit (1:5000) or anti-
mouse (1:10,000) secondary antibodies. Blots were 
washed again for 3 × 15 min with TBST before chemi-
luminescence detection using Immobilon Western 
Chemiluminescent HRP Substrate (Millipore; Billerica, 
MA), according to manufacturer’s instructions. RIPA 
extract lysates of U2OS cells transfected with mamma-
lian expression constructs of V5-CK1α (Addgene plas-
mid #92014, pCAGImC_V5-CSNK1A1, a gift from 
Joshua Mendell), CK1δ-V5His, HA-CK1ε (Addgene 
plasmid #13724, V405 4HA-CKIe, a gift from David 
Virshup), HA-CK2α’ and Myc-CK2β (Addgene plas-
mids #27087 and #27088, pZW16 [CK2alpha’] and 
pZW12 [CK2beta] respectively; gifts from David 
Litchfield) served as positive controls.
Pharmacological treatments
For each drug, cell viability and morphology were 
initially screened over a period of 2 to 4 days using a 
range of concentrations. Concentrations of the drug 
that did not result in hemolysis or altered viability or 
morphology under our experimental conditions (fol-
lowing Henslee et  al., 2017) were chosen for subse-
quent time-course experiments. The drugs used in 
this study—staurosporine, PF-670462, D4476 (all 
Sigma-Aldrich), and TTP22 (Tocris Biosciences; 
Bristol, UK)—were prepared in DMSO according to 
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the manufacturer’s instructions. Drugs were diluted 
in KHB and delivered as a 10X concentration bolus to 
RBC suspensions to achieve the final concentration. 
In each case, an equivalent % of DMSO was used as a 
vehicle control. Drugs were added to RBC suspen-
sions at ZT0 on day 1 (staurosporine) or circadian 
time (CT)-0 on day 3 (PF-670462, D4476, TTP22), as 
indicated in the figure legend. For human U2OS cells, 
PF-670462 was diluted from a 10 mM DMSO stock 
directly into recording medium, and was delivered to 
cells through a media change at the beginning of the 
recording. This was compared with vehicle control 
(between 0.03% to 0.1% DMSO).
sequence Comparisons
The following sequences were compared: the cata-
lytic domain (8-282) and C-terminus (283-end) of 
human CK1 delta isoform 1 (NP_001884), isoform 2 
(NP_620693) and isoform 3 (NP_001350678); the cata-
lytic domain (isoform 1: 16-309; isoforms 2 and 3: 
16-281) and C-terminus (isoform 1: 309-end; isoforms 
2 and 3: 282-end) of human CK1 alpha isoform 1 
(NP_001020276), isoform 2 (NP_001883.4) and iso-
form 3 (NP_001258670.1). Orthologous sequences in 
Arabidopsis thaliana (NP_193170), Neurospora crassa 
(ESA44278), Ostreococcus tauri (OUS42226) and 
Drosophila melanogaster (CK1 alpha: CAA64358; dou-
bletime/discs overgrown: NP_524602) were also 
compared using NCBI protein-protein Basic Local 
Alignment Search Tool (BLASTP) using default 
settings.
Quantification and statistical analysis
All data are presented as the mean ± SEM, where 
n refers to the number of biological replicates. To 
determine whether a circadian rhythm was present in 
time-course experiments, and subsequently the circa-
dian parameters period, amplitude and phase, a 
damped cosine was fit to the data, as described by 
Hirota et  al., (2008), using least squares non-linear 
regression curve fitting in GraphPad Prism (v7.03, 
GraphPad; La Jolla, CA). Briefly, a straight line fit 
(Y X mX c( ) = + ) was compared with a damped 
cosine + baseline fit:
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where X = time, using the extra sum-of-squares F 
comparison test in GraphPad Prism, with the simpler 
model being preferred unless the p value was < 0.05. 
For the calculation of Q10 value, the period values 

















where τ1 and τ2 are the period at temperature T1 
and T2, respectively. T1 = 32°C and T2 = 37°C. Rhythm 
parameters (i.e., period), derived from the best 
fitcosinor, were compared using the extra sum-of-squares 
F comparison test and 2-way ANOVA. If ANOVA 
revealed significant (p < 0.05) effects, Holm-Sidak’s 
multiple comparison post hoc tests were used to 
determine p values for all relevant comparisons. All 
analyses were performed in Graphpad Prism. 
Statistically significant differences were defined as 
those with a p value < 0.05. The significance level is 
indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
results
We previously reported the circadian regulation of 
membrane electrophysiology and potassium trans-
port in isolated human RBCs under constant condi-
tions using an assay based on DEP (Henslee et  al., 
2017). Kinases fulfill essential timing functions in the 
circadian clocks of other mammalian cells (i.e., those 
with nuclei) and we were therefore interested in 
understanding whether this extended to encompass 
the transcription-independent circadian clock of 
RBCs. We used staurosporine, a broad-spectrum 
kinase inhibitor first shown to dramatically alter the 
free-running period in the dinoflagellate Gonyaulax 
polyedra (Comolli and Hastings, 1999), as a proof-of-
principle test of the hypothesis that kinases regulate 
the RBC circadian clock. Staurosporine treatment 
dramatically increased the period of rhythms in 
membrane conductance (Geff) and cytoplasmic con-
ductivity (σcyt) (Fig. 1A-C), similar to its activity in 
nucleated cells (Comolli and Hastings, 1999). RBCs 
are therefore an amenable platform with which to test 
kinase function in the RBC clockwork using small-
molecule inhibitors.
Casein kinases play functionally conserved roles in 
timekeeping across eukaryotes, with roles attributed 
to CK1 homologs (CK1α, CK1δ, CK1ε) and CK2 (He 
et al., 2006; Hirota et al., 2010; Meng et al., 2008; van 
Ooijen et al., 2013). RBCs express one CK1 paralogue, 
CK1α, as well as catalytic and regulatory subunits of 
CK2: CK2α’, and CK2β (Fig. 2A and Supplementary 
Figure S1) (Bryk and Wiśniewski, 2017). Therefore, we 
explored whether their timekeeping role extended to 
non-transcriptional oscillations in RBCs by applying 
casein kinase inhibitors that are known to affect period 


























































Figure 1. rBC circadian rhythms are affected by the inhibition of protein kinases. isolated rBCs were cultured in the presence of 10 
μM staurosporine (sts) or vehicle control at constant 37°C after 2 days of temperature entrainment. deP measurements of membrane 
conductance (Geff) (a) and cytoplasmic conductivity (σcyt) (B) are reported (mean ± seM, n = 4). damped cosine curves were fitted to the 
data using non-linear regression comparison of fits (h1 = damped cosine model, h0 = straight line) extra sum-of-squares F test. Cosine 
fit was preferred over straight line fit if p < 0.05. Geff and σcyt oscillate in antiphase, as previously reported (henslee et al., 2017). (C) sts 
treatment significantly increases the period of both Geff and σcyt rhythms relative to vehicle control (period values derived from best 























































































































Figure 2. Casein kinase inhibition alters the circadian rhythm of red blood cells (rBCs). (a) immunoblots showing the expression pro-
files of human CK1 and CK2 paralogs in human rBCs and in human u2os cells. data from 2 donors are shown. u2os cells transfected 
with V5-CK1α (Golden et al., 2017), CK1δ-V5, ha-CK1ε (rivers et al., 1998), ha-CK2α’ and Myc-CK2β (both turowec et al., 2010) served 
as positive controls. (B-d) dielectrophoresis (deP) measurements of membrane conductance (Geff) in isolated rBCs incubated at con-
stant 37°C over 2 days in the presence of 100 nM ttP22 (CK2 inhibitor) (B), 1 μM d4476 (CK1 inhibitor) (C), or 3 μM PF-670462 (highly 
potent CK1 inhibitor) (d) versus vehicle control (mean ± seM, n = 4. extra sum-of-squares F test p values reported from non-linear 
regression comparison of fits, h1 = damped cosine model, h0 = straight line). (e) the period of Geff rhythms are significantly affected 
by inhibition of CK1 and CK2 (period values derived from best fitcosinor ± seM, n = 4. extra sum-of-squares F test p values reported fol-
lowing comparison of best fitcosinor. **p < 0.01, *p < 0.05).
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determination in nucleated cells (Badura et al., 2007; 
Meng et al., 2010). We found that TTP22, an inhibitor 
of CK2 (Golub et al., 2011), and D4476, an inhibitor of 
CK1 (Bain et al., 2007; Rena et al., 2004), elicited sig-
nificant effects on the period of the circadian rhythm 
in RBC membrane electrophysiology, lengthening, 
and shortening period, respectively (Fig. 2B, C, E). 
This demonstrates a role for these enzymes in the 
transcription-independent time-keeping mechanism 
of RBCs.
A lengthening of the circadian period in response 
to CK2 inhibition has been observed previously for 
other mammalian and eukaryotic models (Tsuchiya 
et al., 2009). We were surprised, however, that CK1 
inhibition elicited a significantly shorter circadian 
period in RBCs compared with controls because, to 
our knowledge, in all other contexts CK1 inhibition 
slows down the cellular clock (Badura et  al., 2007; 
Hirota et  al., 2010; Isojima et  al., 2009; Meng et  al., 
2010; van Ooijen et al., 2013). We therefore repeated 
our assays using a pharmacologically distinct and 
highly potent inhibitor of CK1, PF-670462 (Badura 
et al., 2007; Bibian et al., 2013). This resulted in a simi-
lar reduction in circadian period length as that 
observed with D4476 (Fig. 2D and E).
Temperature compensation is an evolutionarily 
conserved property of the circadian clock and a defin-
ing feature of bona fide circadian rhythms. CK1 and 
CK2 have proposed roles in temperature compensa-
tion in organisms as diverse as Neurospora fungi, 
algae and mammals (Isojima et al., 2009; Mehra et al., 
2009; Tosini and Menaker, 1998; Zhou et al., 2015). We 
examined the role of these cellular kinases in temper-
ature compensation in the absence of known clock 
protein targets. If temperature compensation is reli-
ant on the activity of either kinase, their inhibition 
will result in a Q10 for the period of oscillation that 
lies outside the temperature-compensated range of 
0.8 to 1.2; i.e. inhibition of the kinase should have 
markedly different effects on circadian period at dif-
ferent temperatures. As shown in previous studies in 
nucleated cells (Isojima et al., 2009), inhibition of CK1 
disrupted temperature compensation in (nucleated) 
human U2OS cells expressing a BMAL1:Luc reporter, 
with Q10PF670 = 1.60 ± 0.14 (Fig. 3A and C). Consistent 
with daily rhythms becoming temperature-depen-
dent under CK1 inhibition, in a separate experiment, 
the magnitude of period lengthening due to CK1 
inhibition was further reduced in U2OS cells when 
cultured at the higher temperature of 40°C 
(Supplementary Figure S2). In contrast, CK2 inhibi-
tion had no effect on temperature compensation, i.e. 
Q10TTP22 (1.15 ± 0.13) was not significantly different 
from the vehicle Q10control (1.02 ± 0.11, Fig. 3C). In anu-
cleate RBCs, as with U2OS cells, temperature com-
pensation was observed both for vehicle control 











































10 0.94 ± 0.24 2.60 ± 0.46 0.74 ± 0.43
* n.s.

























































Figure 3. temperature compensation of rBC circadian rhythms is abolished by inhibition of casein kinase 1 (CK1). (a) nucleated 
human u2os cells (BMAL1:Luc) were cultured at constant 32°C (top, light tone) and 37°C (bottom, full tone) following 4 days of tem-
perature entrainment in the presence of 0.31 µM PF-670462 (CK1 inhibitor, red) or 2.5 µM ttP22 (CK2 inhibitor, blue) vs. vehicle control 
(black) (mean ± seM, n = 6), detrended using a moving average of 24-h for vehicle and ttP22 or 30-h for PF-670462. (B) dielectro-
phoretic (deP) measurements of membrane conductance (Geff) in isolated rBCs over 2 days incubated at 32°C in the presence of 3 μM 
PF-670462 (light red) or 100 nM ttP22 (light blue) vs. vehicle control (mean ± seM, n = 4). P values for deP assays report non-linear 
regression comparison of fits (h1 = damped cosine model, h0 = straight line). (C and d) inhibition of CK1 abolishes temperature 
compensation in u2os (top) and rBCs (bottom). in vehicle control (black) and ttP22-treated (blue) cells, period does not change with 
increased temperature, reflected by a Q10 of approximately 1. Conversely, treatment with PF-670462 results in a significantly increased 
Q10 vs. control, reflected by the shorter period at 37°C relative to 32°C. Period values derived from best fitcosinor ± seM (nu2os = 6, nrBC 
= 4). holm-sidak’s multiple comparisons p-value reported, following one-way anoVa (panoVarBC = 0.015, panoVau2os = 0.017), for Q10 
vs. vehicle. *p < 0.05.
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cultures (Q10control = 0.94 ± 0.24) and TTP22-treated 
RBCs (Q10TTP22 = 0.74 ± 0.43) (Fig. 3B and D). Again, 
as with U2OS cells, CK1 inhibition abolished temper-
ature compensation of circadian rhythms in isolated 
RBCs, with period lengthening at 32°C as compared 
with period shortening at 37°C, and a Q10PF670 of 2.60 
± 0.46 (Fig. 3B and D). Therefore, inhibition of CK1, 
but not CK2, activity abolished temperature compen-
sation of circadian rhythms in the presence and 
absence of transcription-translation feedback loops 
(Fig. 3C and D).
disCussion
Both CK1 and CK2 play roles in circadian period 
determination in many eukaryotic cellular contexts 
(O’Neill et  al., 2013). CK1 and CK2 homologs are 
present in RBCs (this study and Bryk and Wiśniewski, 
2017), whereas the capacity for nascent transcription 
is not. Here, we have extended the timekeeping func-
tion for these ancient and ubiquitously expressed 
kinases to encompass regulation of circadian period 
in the non-transcriptional RBC clock. Whilst it is clear 
that PER (and other clock gene encoded) proteins are 
functionally relevant substrates for CK1 and CK2 in 
cells where cycling clock gene transcription is pres-
ent, our RBC assays suggest clock protein transcrip-
tion factors (TFs) are unlikely to be their only relevant 
substrates with respect to cellular timekeeping. 
Separately, this is also implied by the complete con-
servation of CK1 and CK2 in period determination 
across eukaryotes (Causton et al., 2015; He et al., 2006; 
Lin et al., 2002; Meng et al., 2008; Tsuchiya et al., 2009; 
van Ooijen et al., 2013; Yang et al., 2002; Zhang et al., 
2013), whereas the clock protein TFs, upon which 
they act, are not. A parsimonious interpretation of 
this observation is that there exist one or more CK 
substrates, evolutionarily conserved but as yet 
unidentified, whose activity determines periodicity.
In the absence of cycling transcription and clock 
gene activity, we also found that the catalytic activity 
of CK1, but not CK2, appears to be relevant to the 
mechanisms that facilitate temperature compensa-
tion of RBC circadian rhythms, similar to the results 
of nucleated mammalian cells. In two very different 
human cell types, primary RBCs and the U2OS osteo-
sarcoma cell line, inhibition of CK1 abolished tem-
perature compensation and increased the Q10 for the 
period of oscillation. Inhibition of CK1 with PF-670462 
had a greater effect on the Q10 of rhythms in RBCs 
than in U2OS cells (Q10 of 2.6 compared with 1.6, 
respectively), thus explaining the period shortening 
elicited by CK1 inhibition in RBCs at 37°C (Fig. 3 and 
Supplemental Figure S2). The differential sensitivity 
of Q10 to CK1 inhibition between the two cell types 
may be attributable to cell type-dependent variation 
in the expression of CK1 isoforms; i.e., in U2OS cells, 
the α, δ, and ε isoforms were all readily detectable, 
whereas only CK1α was detected in RBCs, both in 
our study and in an independent mass spectrometry-
based investigation (Bryk and Wiśniewski, 2017).
Unlike CK1δ/ε, the timekeeping functions of 
CK1α are less well established, being reported by two 
separate studies (Hirota et al., 2010; Lam et al., 2018). 
Thus, an alternative interpretation of our findings is 
that temperature-compensated circadian rhythms in 
RBCs arise by a completely different mechanism from 
that which operates in other mammalian cell types. In 
this case, the similar sensitivity to CK inhibition of 
RBC circadian rhythms compared with other cell 
types, as well as their common features, such as 
rhythmic K+ transport and over-oxidised peroxire-
doxin levels (Cho et  al., 2014; Edgar et  al., 2012; 
Feeney et al., 2016; Henslee et al., 2017; O’Neill and 
Reddy, 2011), is simply coincidental. We note, how-
ever, that the CK1α catalytic domain shares very high 
sequence identity with human CK1δ/ε (78%) and 
CK1 orthologs in the metazoan, fungal and green lin-
eages (>71%), whereas the C-terminal domains that 
distinguish mammalian CK1 paralogs and isoforms 
from each other show much less conservation across 
the eukaryotic kingdoms. We also note that, whilst 
CK1ε is dispensable, CK1δ and CK1α both play 
essential roles in development and proliferation, pos-
sess identical substrate specificities that cannot be 
distinguished pharmacologically, and have many cel-
lular targets in common (Schittek and Sinnberg, 
2014). Therefore, we suggest that there is very little 
evidence that CK1α is not equally as important as 
CK1δ for the regulation of circadian gene expression 
rhythms in mammalian cells.
Unlike most enzymes (including CK2), the activity 
of CK1δ/ε toward certain polypeptides is insensitive 
to temperature, with a Q10 of around 1.0 (Isojima 
et al., 2009; Shinohara et al., 2017; Zhou et al., 2015). 
This temperature insensitivity is inherent to the cata-
lytic domain of CK1, demonstrated by impaired tem-
perature compensation of catalytic mutants against 
synthetic substrates compared with native sequences 
(Shinohara et al., 2017). This “temperature-compen-
sated domain” is conserved in other CK1δ homologs, 
such as human CK1α (86% similarity), including the 
critical lysine residue (K224 in CK1δ; K232 in CK1α). 
This strongly suggests that temperature compensa-
tion is a function of CK1 homologs across the eukary-
otic kingdom, independent of the presence or absence 
of the TTFL, and functions similarly between nucle-
ated and non-nucleated cells.
In this, we note similarities with KaiC phosphory-
lation in cyanobacteria, whose post-translational 
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rhythm persists in the absence of nascent gene 
expression (Nakajima et al., 2005; Tomita et al., 2005). 
Here, temperature compensation of circadian period 
is conferred by the intrinsically temperature-insensi-
tive phosphotransferase activity of KaiC (Egli et al., 
2012; Terauchi et al., 2007), with circadian period and 
temperature compensation also being sensitive to 
amino acid substitution around the ATP-binding site 
(Murakami et  al., 2008; Terauchi et  al., 2007). Our 
present observations support the possibility that the 
role of CK1 homologs in eukaryotic circadian 
rhythms may be functionally analogous to that of 
KaiC in cyanobacteria (Merrow et  al., 2006; Wong 
and O’Neill, 2018).
The circadian clock regulates biological functions, 
such as metabolism, protein synthesis, and ion trans-
port, in many cell types across phylogenetic king-
doms, both in the presence and absence of 
transcriptional feedback cycles (Cho et  al., 2014; 
Feeney et al., 2016; Henslee et al., 2017; Lipton et al., 
2015; O’Neill et  al., 2011; O’Neill and Reddy, 2011; 
van Ooijen et  al., 2011; Woolum, 1991). Though no 
definitive adaptive advantage has been ascribed to 
RBC circadian rhythms, daily variation in CO2-
carrying potential, adverse cardiovascular events, 
and osmotic homeostasis are potential consequences 
of this reduced and highly specialised cellular clock-
work (Henslee et al., 2017). Erythrocytes are the most 
numerous cell type in the human body. Whereas 
their circadian clock mechanism is not understood, it 
does involve the same conserved kinases that regu-
late timekeeping fidelity in other mammalian cell 
types. Future studies should identify which RBC 
proteins might be subject to circadian post-transla-
tional modification by CK1 and CK2, and whether 
these also exhibit phosphorylation rhythms in other 
cell types.
aCKnoWledGMents
We are grateful to the donors and the Clinical Research 
Centre at the University of Surrey for assistance with the 
blood samples, and Michael P. Hughes and members of the 
O’Neill lab for useful discussions. This research was sup-
ported by a Biotechnology and Biological Research Council 
(BBSRC) grant (BB/M021556/1) and the Medical Research 
Council (MC_UP_1201/4).
ConFliCt oF interest stateMent
The author(s) have no potential conflicts of interest with 
respect to the research, authorship, and/or publication of 
this article.
note
Supplemental material is available for this article online.
orCid id
Andrew D. Beale  https://orcid.org/0000-0002-2051-0919
reFerenCes
Badura L, Swanson T, Adamowicz W, Adams J, Cianfrogna 
J, Fisher K, Holland J, Kleiman R, Nelson F, Reynolds 
L, et al. (2007) An inhibitor of casein kinase I epsilon 
induces phase delays in circadian rhythms under free-
running and entrained conditions. J Pharmacol Exp 
Therap 322:730-738.
Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, Mclauchlan 
H, Klevernic I, Arthur JSC, Alessi DR and Cohen P 
(2007) The selectivity of protein kinase inhibitors: a fur-
ther update. Biochem J 408:297-315.
Balsalobre A, Damiola F, and Schibler U (1998) A serum 
shock induces circadian gene expression in mamma-
lian tissue culture cells. Cell 93:929-937.
Beale AD, Whitmore D, and Moran D (2016) Life in a 
dark biosphere: a review of circadian physiology in 
“arrhythmic” environments. J Comp Physiol B 186:947-
968.
Bibian M, Rahaim RJ, Choi JY, Noguchi Y, Schürer S, Chen 
W, Nakanishi S, Licht K, Rosenberg LH, Li L, et al. 
(2013) Development of highly selective casein kinase 
1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative 
properties. Bioorg Med Chem Lett 23:4374-4380.
Bryk AH and Wiśniewski JR (2017) Quantitative analysis 
of human red blood cell proteome. J Proteome Res 
16:2752-2761.
Causton HC, Feeney KA, Ziegler CA and O’Neill JS (2015) 
Metabolic cycles in yeast share features conserved 
among circadian rhythms. Curr Biol 25:1056-1062.
Cho C-S, Yoon HJ, Kim JY, Woo HA and Rhee SG (2014) 
Circadian rhythm of hyperoxidized peroxiredoxin II is 
determined by hemoglobin autoxidation and the 20S 
proteasome in red blood cells. Proc Natl Acad Sci U S 
A 111:12043-12048.
Comolli JC and Hastings JW (1999) Novel effects on the 
Gonyaulax circadian system produced by the pro-
tein kinase inhibitor staurosporine. J Biol Rhythms 
14:11-19.
Crosby P, Hoyle NP, and O’Neill JS (2017) Flexible measure-
ment of bioluminescent reporters using an automated 
longitudinal luciferase imaging gas- and temperature-
optimized recorder (ALLIGATOR). J Visualized Exp 
(130):1-7.
152 JOURNAL OF BIOLOGICAL RHYTHMS / April 2019
Dekens MPS, Santoriello C, Vallone D, Grassi G, Whitmore 
D and Foulkes NS (2003) Light regulates the cell cycle 
in zebrafish. Curr Biol 13:2051-2057.
Dibner C, Sage D, Unser M, Bauer C, D’Eysmond T, Naef 
F and Schibler U (2009) Circadian gene expression is 
resilient to large fluctuations in overall transcription 
rates. EMBO J 28:123-134.
Edgar RS, Green EW, Zhao Y, van Ooijen G, Olmedo M, 
Qin X, Xu Y, Pan M, Valekunja UK, Feeney KA, et al. 
(2012) Peroxiredoxins are conserved markers of circa-
dian rhythms. Nature 485:459-464.
Egli M, Mori T, Pattanayek R, Xu Y, Qin X and Johnson 
CH (2012) Dephosphorylation of the core clock pro-
tein KaiC in the cyanobacterial KaiABC circadian 
oscillator proceeds via an ATP synthase mechanism. 
Biochemistry 51:1547-1558.
Feeney KA, Hansen LL, Putker M, Olivares-Yañez C, 
Day J, Eades LJ, Larrondo LF, Hoyle NP, O’Neill JS, 
van Ooijen G, et al. (2016) Daily magnesium fluxes reg-
ulate cellular timekeeping and energy balance. Nature 
532:375-379.
Gallego M and Virshup DM (2007) Post-translational modi-
fications regulate the ticking of the circadian clock. Nat 
Rev Mol Cell Biol 8:139-148.
Golden RJ, Chen B, Li T, Braun J, Manjunath H, Chen X, Wu 
J, Schmid V, Chang T-C, Kopp F, et al. (2017) An argo-
naute phosphorylation cycle promotes microRNA-
mediated silencing. Nature 542:197-202.
Golub AG, Bdzhola VG, Briukhovetska N V., Balanda 
AO, Kukharenko OP, Kotey IM, Ostrynska O V. and 
Yarmoluk SM (2011) Synthesis and biological evalua-
tion of substituted (thieno[2,3-d]pyrimidin-4-ylthio)
carboxylic acids as inhibitors of human protein kinase 
CK2. Eur J Med Chem 46:870-876.
He Q, Cha J, He Q, Lee HC, Yang Y and Liu Y (2006) CKI 
and CKII mediate the FREQUENCY-dependent phos-
phorylation of the WHITE COLLAR complex to close 
the Neurospora circadian negative feedback loop. 
Genes Dev 20:2552-2565.
Henslee EA, Crosby P, Kitcatt SJ, Parry JSW, Bernardini 
A, Abdallat RG, Braun G, Fatoyinbo HO, Harrison EJ, 
Edgar RS, et al. (2017) Rhythmic potassium transport 
regulates the circadian clock in human red blood cells. 
Nat Commun 8:1978.
Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG and Kay 
SA (2008) A chemical biology approach reveals period 
shortening of the mammalian circadian clock by spe-
cific inhibition of GSK-3. Proc Natl Acad Sci U S A 
105:20746-20751.
Hirota T, Lee JW, Lewis WG, Zhang EE, Breton G, Liu X, 
Garcia M, Peters EC, Etchegaray J-P, Traver D, et al. 
(2010) High-throughput chemical screen identifies a 
novel potent modulator of cellular circadian rhythms 
and reveals CKIα as a clock regulatory kinase. PLoS 
Biol 8:e1000559.
Isojima Y, Nakajima M, Ukai H, Fujishima H, Yamada RG, 
Masumoto K -h., Kiuchi R, Ishida M, Ukai-Tadenuma 
M, Minami Y, et al. (2009) CKI epsilon/delta-depen-
dent phosphorylation is a temperature-insensitive, 
period-determining process in the mammalian circa-
dian clock. Proc Natl Acad Sci U S A 106:15744-15749.
Kang T-H, Reardon JT, Kemp M and Sancar A (2009) 
Circadian oscillation of nucleotide excision repair in 
mammalian brain. Proc Natl Acad Sci U S A 106:2864-
2867.
Lakin-Thomas PL (2006) Transcriptional feedback oscilla-
tors: Maybe, maybe not... J Biol Rhythms 21:83-92.
Lam VH, Li YH, Liu X, Murphy KA, Diehl JS, Kwok RS and 
Chiu JC (2018) CK1α collaborates with DOUBLETIME 
to regulate PERIOD function in the Drosophila circadian 
clock. J Neurosci 38:10631-10643.
Lin J-M, Kilman VL, Keegan K, Paddock B, Emery-Le 
M, Rosbash M and Allada R (2002) A role for casein 
kinase 2α in the Drosophila circadian clock. Nature 
420:816-820.
Lipton JO, Yuan ED, Boyle LM, Ebrahimi-Fakhari D, 
Kwiatkowski E, Nathan A, Güttler T, Davis F, Asara 
JM and Sahin M (2015) The circadian protein BMAL1 
regulates translation in response to S6K1-mediated 
phosphorylation. Cell 161:1138-1151.
Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and 
Okamura H (2003) Control mechanism of the circadian 
clock for timing of cell division in vivo. Science 302:255-
259.
Mehra A, Shi M, Baker CL, Colot H V., Loros JJ and Dunlap 
JC (2009) A role for casein kinase 2 in the mechanism 
underlying circadian temperature compensation. Cell 
137:749-760.
Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, 
Brown TM, Sládek M, Semikhodskii AS, Glossop NRJ, 
Piggins HD, et al. (2008) Setting clock speed in mam-
mals: The CK1ε tau mutation in mice accelerates circa-
dian pacemakers by selectively destabilizing PERIOD 
proteins. Neuron 58:78-88.
Meng QJ, Maywood ES, Bechtold DA, Lu W-Q, Li J, Gibbs 
JE, Dupre SM, Chesham JE, Rajamohan F, Knafels J, 
et al. (2010) Entrainment of disrupted circadian behav-
ior through inhibition of casein kinase 1 (CK1) enzymes. 
Proc Natl Acad Sci U S A 107:15240-15245.
Merrow M, Mazzotta G, Chen Z and Roenneberg T (2006) 
The right place at the right time: regulation of daily 
timing by phosphorylation. Genes Dev 20:2629-2633.
Murakami R, Miyake A, Iwase R, Hayashi F, Uzumaki T 
and Ishiura M (2008) ATPase activity and its tempera-
ture compensation of the cyanobacterial clock protein 
KaiC. Genes Cells 13:387-395.
Nakajima M, Imai K, Ito H, Nishiwaki T, Murayama Y, 
Iwasaki H, Oyama T and Kondo T (2005) Reconstitution 
of circadian oscillation of cyanobacterial KaiC phos-
phorylation in vitro. Science 308:414-415.
Beale et al. / TEMPERATURE COMPENSATION OF THE RBC CIRCADIAN CLOCK 153
O’Neill JS and Reddy AB (2011) Circadian clocks in human 
red blood cells. Nature 469:498-503.
O’Neill JS, Van Ooijen G, Dixon LE, Troein C, Corellou F, 
Bouget FY, Reddy AB and Millar AJ (2011) Circadian 
rhythms persist without transcription in a eukaryote. 
Nature 469:554-558.
O’Neill JS, Maywood ES and Hastings MH (2013) Cellular 
mechanisms of circadian pacemaking: Beyond tran-
scriptional loops. In: Kramer A and Merrow M (eds), 
Circadian Clocks. Handbook of Experimental Pharmacology. 
Berlin, Heidelberg: Springer, pp 63-103.
Pittendrigh CS (1960) Circadian Rhythms and the Circadian 
Organization of Living Systems. Cold Spring Harbor 
Symp Quant Biol 25:159-184.
Rena G, Bain J, Elliott M and Cohen P (2004) D4476, a cell-per-
meant inhibitor of CK1, suppresses the site-specific phos-
phorylation and nuclear exclusion of FOXO1a. EMBO Rep 
5:60-65.
Rivers A, Gietzen KF, Vielhaber E and Virshup DM (1998) 
Regulation of casein kinase I ε and casein kinase I δ by 
an in vivo futile phosphorylation cycle. J Biol Chem 
273:15980-15984.
Schittek B and Sinnberg T (2014) Biological functions of 
casein kinase 1 isoforms and putative roles in tumori-
genesis. Mol Cancer 13:231.
Shinohara Y, Koyama YM, Ukai-Tadenuma M, Hirokawa 
T, Kikuchi M, Yamada RG, Ukai H, Fujishima H, 
Umehara T, Tainaka K, et al. (2017) Temperature-
sensitive substrate and product binding underlie tem-
perature-compensated phosphorylation in the clock. 
Mol Cell 67:783-798.e20.
Takahashi JS (2017) Transcriptional architecture of the 
mammalian circadian clock. Nat Rev Genet 18:164-179.
Terauchi K, Kitayama Y, Nishiwaki T, Miwa K, Murayama 
Y, Oyama T and Kondo T (2007) ATPase activity of 
KaiC determines the basic timing for circadian clock 
of cyanobacteria. Proc Natl Acad Sci U S A 104:16377-
16381.
Tomita J, Nakajima M, Kondo T and Iwasaki H (2005) No 
transcription-translation feedback in circadian rhythm 
of KaiC phosphorylation. Science 307:251-254.
Tosini G and Menaker M (1998) The tau mutation affects 
temperature compensation of hamster retinal circadian 
oscillators. NeuroReport 9:1001-1005.
Tsuchiya Y, Akashi M, Matsuda M, Goto K, Miyata Y, 
Node K and Nishida E (2009) Involvement of the pro-
tein kinase CK2 in the regulation of mammalian circa-
dian rhythms. Sci Signal 2:ra26-ra26.
Turowec JP, Duncan JS, French AC, Gyenis L, St. Denis 
NA, Vilk G and Litchfield DW (2010) Protein kinase 
CK2 is a constitutively active enzyme that promotes 
cell survival: Strategies to identify CK2 substrates and 
manipulate its activity in mammalian cells. In Methods 
in Enzymology, pp 471-493.
van Ooijen G, Dixon LE, Troein C and Millar AJ (2011) 
Proteasome function is required for biological tim-
ing throughout the twenty-four hour cycle. Curr Biol 
21:869-875.
van Ooijen G, Hindle M, Martin SF, Barrios-Llerena M, 
Sanchez F, Bouget FY, O’Neill JS, Le Bihan T, Millar 
AJ, O’Neill JS, et al. (2013) Functional analysis of casein 
kinase 1 in a minimal circadian system. PLoS ONE 
8:e70021.
Vaze KM and Sharma VK (2013) On the adaptive signifi-
cance of circadian clocks for their owners. Chronobiol 
Int 30:413-433.
Welsh DK, Yoo S-H, Liu AC, Takahashi JS and Kay SA 
(2004) Bioluminescence imaging of individual fibro-
blasts reveals persistent, independently phased cir-
cadian rhythms of clock gene expression. Curr Biol 
14:2289-2295.
Wong DC and O’Neill JS (2018) Non-transcriptional pro-
cesses in circadian rhythm generation. Curr Opin 
Physiol 5:117-132.
Woolum JC (1991) A re-examination of the role of the 
nucleus in generating the circadian rhythm in acetabu-
laria. J Biol Rhythms 6:129-136.
Yang Y, Cheng P, and Liu Y (2002) Regulation of the 
Neurospora circadian clock by casein kinase II. Genes 
Dev 16:994-1006.
Zhang L, Hastings MH, Green EW, Tauber E, Sladek M, 
Webster SG, Kyriacou CP and Wilcockson DC (2013) 
Dissociation of circadian and circatidal timekeeping 
in the marine crustacean Eurydice pulchra. Curr Biol 
23:1863-1873.
Zhou M, Kim JK, Eng GWL, Forger DB and Virshup DM 
(2015) A period2 phosphoswitch regulates and temper-
ature compensates circadian period. Mol Cell 60:77-88.
